Open Access

Erratum to: Establishing medical plausibility in the context of orphan medicines designation in the European Union

  • Stelios Tsigkos1Email author,
  • Segundo Mariz1,
  • Jordi Llinares1,
  • Laura Fregonese1,
  • Stiina Aarum1,
  • Frauke Naumann-Winter2,
  • Kerstin Westermark3 and
  • Bruno Sepodes4
Orphanet Journal of Rare Diseases201510:129

https://doi.org/10.1186/s13023-015-0309-7

Received: 17 July 2015

Accepted: 17 July 2015

Published: 6 October 2015

The original article was published in Orphanet Journal of Rare Diseases 2014 9:175

Erratum

After publication of [1] it came to the authors’ attention that Frauke Naumann-Winter’s name was displayed incorrectly. The correct spelling of their name is included in this erratum.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Orphan Medicines Office, European Medicines Agency
(2)
Bundesinstitut für Arzneimittel und Medizinprodukte
(3)
Läkemedelsverket
(4)
Research Institute for Medicines (iMED.ULisboa), Faculty of Pharmacy, University of Lisbon

References

  1. Tsigkos S, Mariz S, Llinares J, Fregonese L, Aarum S, Frauke N, et al. Establishing medical plausibility in the context of orphan medicines designation in the European Union. Orphanet Journal of Rare Diseases. 2014; 9:175.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© Tsigkos et al. 2015

Advertisement